![Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/d6219c58-2385-4eea-93ff-0243ce87d824/gr1.gif)
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine
![Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044532319300387-gr2.jpg)
Type I interferon signaling, regulation and gene stimulation in chronic virus infection - ScienceDirect
![Interferon and ribavirin for chronic hepatitis C: should it be administered in the new treatment era? Interferon and ribavirin for chronic hepatitis C: should it be administered in the new treatment era?](https://actagastro.org/wp-content/uploads/2017/04/MO-15-051-IMG03.jpeg)
Interferon and ribavirin for chronic hepatitis C: should it be administered in the new treatment era?
![Interferon therapy for COVID-19 and emerging infections: Prospects and concerns | Cleveland Clinic Journal of Medicine Interferon therapy for COVID-19 and emerging infections: Prospects and concerns | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/early/2020/12/01/ccjm.87a.ccc066/F1.large.jpg)
Interferon therapy for COVID-19 and emerging infections: Prospects and concerns | Cleveland Clinic Journal of Medicine
![Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides - JDDonline - Journal of Drugs in Dermatology Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides - JDDonline - Journal of Drugs in Dermatology](https://s3.amazonaws.com/dl.jddonline.com/articleimages/20_3_WALKER/Clinical_Trial_of_High_Dose_Pegylated_Interferon_Alfa_2b_Combined_With_Phototherapy_in_Advanced_Stage_Mycosis_Fungoides_Table2.jpg)
Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides - JDDonline - Journal of Drugs in Dermatology
![Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - ScienceDirect Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S027869152200206X-ga1.jpg)
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs - ScienceDirect
![Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial - The Lancet Neurology Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/2000992161/2003663757/gr1.gif)